Boosters

Under RFK Jr policy changes, COVID shots could cost $200 for those under 65

Thu, 2025-05-29 16:13 — mike kraft

Want a COVID vaccine? It could cost you $200. The Trump administration's COVID-19 vaccine policy changes mean anyone who is healthy and under 65 will likely have to pay out of pocket for the shot. Karen Weintraub USA TODAY

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Under RFK Jr policy changes, COVID shots could cost $200 for those under 65
1 comment
Log in or register to post comments

RFK Jr's CDC recomendations to drop COVID vaccinations for healthy children, pregnant woman criticized by specialists

Wed, 2025-05-28 22:29 — mike kraft

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access The CDC stopped recommending Covid shots for healthy children and pregnant women, while Hinge Health makes its debut on the New York Stock Exchange. Annika Kim Constantino,Ashley Capoot CNBC

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant.

Fri, 2025-05-23 17:50 — mike kraft

Vaccine advisers to the FDA recommended changes to COVID vaccines Advisers to the Food and Drug Administration met Thursday to help decide which variant of the virus that causes COVID should be targeted by updated versions of the vaccines. NPR

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant.
Log in or register to post comments

Opinion: Transparency needed in Trump administration's key COVID vaccine decisions

Thu, 2025-05-22 17:26 — mike kraft

Viewpoint: Making key COVID vaccine decisions without input, transparency is a public disservice Strengthening trust in public health, especially around big changes to vaccine policy, requires transparency, including letting the American people know what data you're using to make them. CIDRAP

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Other

Read more about Opinion: Transparency needed in Trump administration's key COVID vaccine decisions
Log in or register to post comments

U.S. FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

Thu, 2025-05-22 17:16 — mike kraft

FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation | CNN The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination. Jen Christensen CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
Log in or register to post comments

U.S.FDA will limit access to Covid-19 boosters for Americans under 65

Wed, 2025-05-21 00:45 — mike kraft

FDA says it will limit access to Covid-19 boosters for Americans under 65 Critics say shift will negatively impact people who are not high-risk but want to be vaccinated against the disease The Guardian

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S.FDA will limit access to Covid-19 boosters for Americans under 65
Log in or register to post comments

U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.

Mon, 2025-05-19 13:42 — mike kraft

After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk | CNN After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter from the agency, but only for people 65 and older and those 12 and up who have at least one underlying condition that puts them at higher risk of severe illness. Katherine Dillinger CNN

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.
Log in or register to post comments

Trump admnistration's $500 million for old vaccine technology raises questions

Mon, 2025-05-05 16:37 — mike kraft

Trump Team’s $500 Million Bet on Old Vaccine Technology Puzzles Scientists - KFF Health News Secretary Robert F. Kennedy Jr.’s HHS said an enormous, noncompetitive flu vaccine development grant to two favored NIH leaders would ensure “transparency, effectiveness, and comprehensive preparedness.” But their vaccine is in early stages, relies on old technology, and is just one of scores of similar efforts. khnkit KFF Health News

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Other

Read more about Trump admnistration's $500 million for old vaccine technology raises questions
Log in or register to post comments

U.S. HHS plans research on universal flu, coronavirus vaccine, while casting doubt on future of Covid-19 booster shots

Fri, 2025-05-02 15:41 — mike kraft

HHS touts universal flu, coronavirus vaccine initiative while casting doubt on future of seasonal Covid-19 shots | CNN The US Department of Health and Human Services said Thursday that it aims to accomplish within four years a scientific feat that hasn’t been achieved for the past 45: the development of a universal flu vaccine that could protect against multiple virus strains with pandemic potential, including H5N1 avian influenza. Meg Tirrell, Brenda Goodman CNN

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Solutions

Situation Report

Vaccine delay: Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay

Thu, 2025-05-01 15:37 — mike kraft

Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay Moderna is deprioritizing< | Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its operating expenses. The biotech disclosed the changes alongside news of a delay to the expected approval of the vaccine in older adults. Nick Paul Taylor Fierce Biotech

...

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Vaccine delay: Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay
Log in or register to post comments

Resilience System

Main menu

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Boosters

Under RFK Jr policy changes, COVID shots could cost $200 for those under 65

RFK Jr's CDC recomendations to drop COVID vaccinations for healthy children, pregnant woman criticized by specialists

U.S. FDA advisors recommend vaccine manufacturers target strains related to JN.1 variant.

Opinion: Transparency needed in Trump administration's key COVID vaccine decisions

U.S. FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation

U.S.FDA will limit access to Covid-19 boosters for Americans under 65

U.S. FDA approves Novavax's COVID-19 vaccine but only for older and high risk people.

Trump admnistration's $500 million for old vaccine technology raises questions

U.S. HHS plans research on universal flu, coronavirus vaccine, while casting doubt on future of Covid-19 booster shots

Vaccine delay: Moderna's flu/COVID combination vaccine hit by deprioritization, FDA delay

Pages

Resilience System

Main menu

User login

Search form

Language

Anonymous's groups in this site

Your groups across all your sites

Recent Content

Recent Comments

Who's online

You are here

Boosters

Pages